Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo

by Cheng, Mingrong, Gao, Xiaoyan, Wang, Yong, Chen, Houxiang, He, Bing, Li, Yingchun, Han, Jiang, Zhang, Zhiping
Published 2013

Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics

by Cheng, Mingrong, Chen, Houxiang, Wang, Yong, Xu, Hongzhi, He, Bing, Han, Jiang, Zhang, Zhiping
Published 2014

Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo

by Cheng, Mingrong, Gao, Xiaoyan, Wang, Yong, Chen, Houxiang, He, Bing, Xu, Hongzhi, Li, Yingchun, Han, Jiang, Zhang, Zhiping
Published 2013

Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells

by Cheng, Mingrong, Xu, Hongzhi, Wang, Yong, Chen, Houxiang, He, Bing, Gao, Xiaoyan, Li, Yingchun, Han, Jiang, Zhang, Zhiping
Published 2013

5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma via Activation of the p53 Pathway in the Orthotopic Transplant Mouse Model

by Cheng, Mingrong, He, Bing, Wan, Tao, Zhu, Weiping, Han, Jiang, Zha, Bingbing, Chen, Houxiang, Yang, Fengxiao, Li, Qing, Wang, Wei, Xu, Hongzhi, Ye, Tao
Published 2012